Original Article
Author Details :
Volume : 8, Issue : 3, Year : 2023
Article Page : 153-156
https://doi.org/10.18231/j.jdpo.2023.035
Abstract
Background: Oral cancer is the sixth most common cancer worldwide. Despite new modalities of treatment there has been no significant improvement in mortality and morbidity. E-cadherin responsible for cell-cell adhesion in epithelial tissues. It plays role in establishment and maintenance of polarity and structural integrity. Low expression helps in process of carcinogenesis. Epidermal growth factor receptor (EGFR) overexpression is found in majority of oral squamous cell carcinoma and association have been made between increased expression levels and an aggressive phenotype.
Aim of study: To study the association of E-cadherin with epidermal growth factor receptor in different grades of oral squamous cell carcinoma.
Materials and Methods: After taking informed consent from patients 75 cases of OSCC were included in the study and subjected to immunohistochemistry of E-cadherin and EGFR.
Results: It was concluded from the study that with decrease in differentiation of OSCC expression of E- cadherin decrease while expression of EGFR increases. On correlating both were found to be inversely proportional to each other.
Conclusions: During EMT there is loss of cell adhesion molecules. In our study with decrease differentiation there is loss of E-cadherin. E-Cadherin expression was inversely correlated to EGFR expression.
Keywords: Oral cancer, Ecadherin, EGFR, Squamous Cell carcinoma
How to cite : Usman S I, Maheshwari V, Afroz N, Ahmed M, Association of E-cadherin with epidermal growth factor receptor in squamous cell carcinoma of oral cavity. IP J Diagn Pathol Oncol 2023;8(3):153-156
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 04-06-2023
Accepted : 02-08-2023
Viewed: 582
PDF Downloaded: 221